Healthcare Compliance Manager

Noom appoints Jim Bugden Chief Financial Officer as company enters next phase of growth. Aug 18, 2026 | Last updated Aug 19, 2026 Source references. Financial and operational leader with deep experience scaling high-growth technology companies joins Noom to support the company's continued expansion. PRINCETON, NJ - August 18, 2026 - Noom, the leading behavior change company, today announced that Jim Bugden has been named Chief Financial Officer. In this role, Bugden oversees Noom's global financial strategy and operations, supporting the company's continued expansion as it builds its comprehensive prescription-grade wellness platform. "Jim brings exactly the financial and operational leadership that Noom needs at this stage of our growth," said Geoff Cook, CEO of Noom. "He has spent his career building the financial infrastructure that allows companies to scale efficiently through periods of complex growth and operational integration. As we expand into new categories and continue to build out our clinical platform, having Jim at the helm of our finance organization is a major advantage." Bugden brings extensive experience leading financial strategy at high-growth technology and consumer companies. Prior to Noom, he served as Chief Financial Officer and Vice President of Video for The Meet Group, a leading social discovery and live-streaming video company. He served as CFO throughout The Meet Group's time as a publicly traded, NASDAQ-listed company, through its 2020 sale to ProSieben, managing significant periods of growth and leading four acquisitions in addition to the sale itself. Bugden has held additional financial and operational leadership roles across a range of businesses, building deep expertise in scaling operations, managing growth, fundraising, and special transactions, including mergers and acquisitions. He served as CFO in Residence at First Round Capital, one of the leading seed-stage venture capital firms, where he advised early-stage founders on building the financial and operational foundations for growth. Bugden also served as CFO of Solve Media, and previously held the position SVP of Corporate Development and Partnerships at Noom. "Noom is at an exciting inflection point," said Bugden. "We're expanding our clinical platform, entering new product categories, and deepening our engagement and relationships with members across the full spectrum of health. I'm proud to join Noom's already strong leadership bench at this moment and look forward to building the financial infrastructure that supports the Company's growth." About Noom: Noom is the leading behavior change company, empowering everyone, everywhere to live better longer - every day. Noom pairs sustainable behavior change with prescription-grade catalysts to make lasting change feel easy. Noom Health partners with top health plans and employers to offer millions of Americans a suite of metabolic health solutions - including Noom Clinical (Noom Med, Noom SmartRx, and NoomRx programs), Noom Weight, Noom Diabetes, and Noom Diabetes Prevention Program. Noom is building the future of preventive care and longevity medicine, leading the convergence of wearable-monitored behavior change, clinical care, diagnostics, and pharmacy into an integrated, AI-enhanced system that drives individualized, meaningful health outcomes. Noom has received multiple grants from the NIH for digital health research and innovation and has been recognized by the CDC for its groundbreaking diabetes prevention programs. Headquartered in Princeton, NJ and with additional offices in New York City, Noom has been recognized as a TIME100 Industry Leader, on Newsweek's Most Trusted Brands list, as well as by Inc. and Fortune as a best place to work. Learn more at noom.com, subscribe to its blog, or follow Noom, Inc. on Twitter and LinkedIn.

U.S. News & World Report ranks best GLP-1 telehealth platforms. Key takeaways. * U.S. News has ranked 11 out of 20 online platforms as the Best GLP-1 Telehealth Platforms, including Amazon One Medical, Found, Ivim Health, and Noom. * The organization says the ranking aims to bring clarity for US consumers, as finding transparent cost details and support data can be challenging. * The team ranked clinical support, screening rigor, transparency, insurance assistance, supplemental care, and overall customer satisfaction. U.S. News & World Report has announced ratings for the Best GLP-1 Telehealth Platforms, with 11 out of 20 platforms receiving top grades. These include Amazon One Medical, Found, Ivim Health, and Noom. The ratings evaluated online platforms that offer US FDA-approved, branded versions of the weight loss drug to help consumers navigate the growing digital weight management marketplace. The platforms were evaluated across six pillars: clinical support, screening rigor, transparency, insurance assistance, supplemental care, and overall customer satisfaction. "Finding transparent cost details and reliable decision support data is often confusing to consumers," says Gretel Schueller, managing editor of health at U.S. News. "U.S. News' GLP-1 telehealth platform ratings were created to bring clarity to a complex marketplace." "By thoroughly evaluating platforms across six unique patient-focused pillars, we aim to help American consumers confidently choose a platform - in consultation with their doctor - that aligns with their budget and health goals." The new ranking follows a U.S. News survey from January, where 52% of health and nutrition experts predicted the expanded use of GLP-1s would be the trend that makes the most significant impact on public health this year. Experts underscore the importance of a healthy diet and exercise to accompany weight management medication. The growing adoption of GLP-1s is also driving the food, beverage, and supplement industries to support consumers on these drugs and when they transition off them. Ingredient suppliers point to protein, fiber, and micronutrients as the most important deficiencies for people using these medications. Online health support. According to U.S. News, millions of US citizens are turning to online platforms to access GLP-1 medication. However, the company cautions that finding transparent and reliable options is difficult as users have to navigate complicated fee structures, different levels of doctor oversight, and complex insurance processes. The 11 best rated platforms are Amazon One Medical, Found, Fridays, Ivim Health, LifeMD, Mochi Health, Noom, PlusCare, Remedy Meds, Ro, and WeightWatchers.The Health team at U.S. News collected 14,161 data points to evaluate the platforms offering medications such as Wegovy, Zepbound, Ozempic, and Foundayo via online services in the US. It excluded platforms that only offer compounded GLP-1 medications - custom-made, non-FDA-approved alternatives that are mixed by pharmacies not connected to manufacturers of the brand-name drugs. The team scored the platforms on a five-point scale across six pillars, each carrying a different weight for the overall rating: clinical support (25% of the final rating), screening rigor (20%), transparency (17%), insurance assistance (15%), supplemental care (13%), and overall customer satisfaction (10%). They assessed the level of clinical support provided and health screening requirements, such as body weight verification or medical records. The team also analyzed the transparency of costs and information on the website and the levels of insurance support offered. Moreover, the ratings analyzed whether other support was offered, such as an app with tracking, diet, and nutrition support. Consumer feedback. The team assessed customer satisfaction through a survey of 1,251 US adults who had used a GLP-1 from an online telehealth platform in the previous year. "The feedback from over 1,200 active GLP-1 users makes one thing clear: when delivered with proper care, digital GLP-1 platforms can be transformational," notes Schueller. "Nearly 85% of survey respondents rated their experience with their telehealth provider as 'very good' or 'excellent,' and nearly two-thirds achieved significant, life-changing weight loss of more than 10% of their body weight - with under 1% reporting no weight loss." She explains that these ratings show that when consumers choose a telehealth platform grounded in high clinical standards, obtaining GLP-1s through telehealth can be an effective and safe way to lose weight. "Out of 20 platforms evaluated, 11 earned top marks by meeting quality standards for patient safety and clinical care, but there is no one-size-fits-all solution," adds Schueller. "Whether a patient needs dedicated insurance concierge support like Amazon One Medical, thorough medical oversight like Found, comprehensive lifestyle and nutrition coaching like Noom, or top-tier customer communication like Ro, these ratings help consumers find the right fit for their specific health journey." Last year, Noom upgraded its app with a GLP-1 Companion service to support people using these medications. The update aimed to help solve the therapies' challenges in persistence and muscle-mass loss.

Noom vs MyFitnessPal: which tracker actually helps? Noom and MyFitnessPal both show up when you search for a calorie tracker, but they solve different problems. MyFitnessPal is a food logging tool built around a database of over 20 million foods. You scan, search, or speak your meals, and it returns the numbers: calories, protein, carbs, fat. Noom is a behaviour-change program built around psychology-based lessons and optional coaching. It includes a food logger, but the logger is a supporting feature, not the core product. That distinction matters. If you already know what to eat and just need a place to track it, one of these is overkill. If you keep abandoning diets after two weeks, the other might not give you enough structure to stick. What Noom actually is. Noom calls itself a "personalized weight-loss experience" rooted in psychology and biology. The program includes daily lessons on topics like emotional eating, habit formation, and cognitive reframing. It pairs these with food logging, weight tracking, and (on some plans) access to a human coach. According to Noom's own pricing page, Noom Weight costs $17.42 per month on a 12-month plan, with a 7-day free trial. That plan includes psychology-based lessons, habit tracking, and optional coaching. For users who want medical support, Noom also offers a GLP-1Rx program starting at $129 with medication included, and a Microdose GLP-1Rx program starting at $79. The food logger inside Noom uses a colour-coded system. Green, yellow, and orange foods are grouped by caloric density. The idea is to steer you toward lower-density options without banning anything outright. But the logger itself is secondary to the lessons and coaching. If you are tracking macros in grams, Noom does not focus on that level of detail. What MyFitnessPal actually is. MyFitnessPal is a calorie and macro tracker with a database that spans over 20 million foods globally. PCMag describes it as "tightly focused on calories" and rates it 4 out of 5, noting its "excellent database of food and nutritional values" and compatibility with many apps and devices. The app connects with 35+ apps and devices for syncing steps, weight, and workouts. Logging tools include barcode scanning, photo-based meal scanning, and voice logging. You can set custom macro goals and track micronutrients beyond the big three. There is no coaching, no psychology curriculum, no daily lessons. MFP assumes you know your goals and gives you the infrastructure to measure against them. The core trade-off: structure vs precision. Noom gives you a framework for changing eating behaviour. Its daily lessons explain why you overeat, why cravings spike at certain times, and how to build routines that hold. The tracking is there, but it is designed to support the coaching rather than stand alone. MyFitnessPal gives you granular nutritional data. You can track grams of protein across every meal, compare your macro split day over day, and log foods from almost any restaurant or packaged product on the planet. But it does not tell you what to do with that data. The interpretation is on you. For someone who has never tracked food before and tends to fall off diets, Noom's structure could help build the habit. For someone who already understands macros and just needs a reliable logging tool, MFP's database depth and device integrations are hard to beat. Pricing side by side. | / | Noom Weight | MFP Free | MFP Premium | MFP Premium+ | | Monthly cost (annual plan) | $17.42 | $0 | ~€6.67 | ~€8.34 | | Monthly cost (month-to-month) | Higher (varies) | $0 | Not listed | €24.99 | | Free trial | 7 days | N/A | 7 days | 7 days | | Food database | Colour-coded system | 20M+ foods | 20M+ foods | 20M+ foods | | Macro tracking | Basic | Yes | Yes (custom goals) | Yes (custom goals) | | Barcode scan | Limited | Paid feature | Yes | Yes | | Coaching | Optional (included) | No | No | No | | Psychology lessons | Yes | No | No | No | | Meal planner | No | No | No | Yes (1,500+ recipes) | | Device integrations | Limited | 35+ apps | 35+ apps | 35+ apps | Noom's pricing reflects the coaching and curriculum. MFP's pricing reflects database access and logging tools. They are priced for different products because they are different products. Where each one falls short. Noom's gap: macro tracking. If you are trying to hit 180g of protein on a lean bulk or dial in a specific carb-to-fat ratio for a cut, Noom's colour system does not provide that resolution. You are working with broad categories (green, yellow, orange) rather than gram-level targets. For anyone following a structured macro plan, that is a real limitation. MFP's gap: behaviour change. The app gives you a dashboard, not a plan. If you open MFP, see you are 400 calories over by 3pm, and have no idea what to do about it, the app will not help you figure that out. PCMag puts it directly: MFP is "tightly focused on calories" and should not be confused for a weight-loss program. There is also the database accuracy question. MFP's food database is largely user-submitted. With 20 million entries, duplicates and incorrect entries exist. You can mitigate this by favouring verified entries and cross-checking against nutrition labels, but it adds friction. Which one works for macro tracking. If you are counting macros in grams, MyFitnessPal is the more capable tool. Custom macro goals, per-meal breakdowns, micronutrient tracking, and a barcode scanner that covers most packaged foods make it purpose-built for that workflow. Noom is not designed for macro tracking. Its food categorisation system groups foods by caloric density, which is useful for portion awareness but does not translate to "I need 40g of protein at this meal." For a deeper look at macro-friendly trackers, see its MyFitnessPal alternatives comparison, which covers apps specifically built around macro targets. If your main question is whether MFP or Lose It handles calorie tracking better, Maccy break that down in Lose It vs MyFitnessPal. The hardgainer angle. If you are trying to gain weight with a fast metabolism, neither Noom nor MFP is specifically designed for that goal. Noom's program is weight-loss oriented by default. MFP is goal-agnostic (you can set it to gain, lose, or maintain), but it does not coach you on calorie-dense food strategies or meal timing for a surplus. For hardgainers, MFP's database depth is the more useful feature. You can log calorie-dense foods precisely, track whether you are actually hitting your surplus target, and see your weekly trend. The 47% underreporting gap that derails most weight gain attempts shows up clearly when you track every meal in an app with granular data. Noom's psychology lessons could help if your problem is consistency (forgetting meals, skipping eating windows), but its food system nudges you toward lower-calorie options, which is the opposite of what a hardgainer needs. Pick based on your actual problem. Choose Noom if: you have tried tracking before and quit, you tend to eat emotionally, you want structured guidance on what and why to eat, and you do not need gram-level macro data. The coaching and daily lessons add value when the core issue is behaviour, not information. Choose MyFitnessPal if: you know your macro targets, you want a fast logging experience with the largest food database available, and you prefer to make your own decisions about what to eat. The free tier handles basic calorie tracking. Premium unlocks the tools (barcode scan, custom macros) that make daily logging fast enough to sustain. Choose neither if: you want an app that sets your macros, adjusts them over time, and tells you what to eat at the gram level without daily psychology lessons. That is a different category of tracker entirely.